Prevalence of Post COVID-19 Condition in Primary Care: A Cross Sectional Study.

COVID-19 general practice post-acute COVID-19 syndrome primary health care public health

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
06 Feb 2022
Historique:
received: 21 12 2021
revised: 28 01 2022
accepted: 03 02 2022
entrez: 15 2 2022
pubmed: 16 2 2022
medline: 19 2 2022
Statut: epublish

Résumé

The COVID-19 pandemic is a major challenge for health systems, citizens and policymakers worldwide. It is not known how many people are affected with longer term sequelae after acute COVID-19 and a wide range of prevalence estimates have been reported with a high heterogeneity between studies. We designed a cross-sectional study to estimate the prevalence of post COVID-19 conditions in a community setting. We selected a random sample of 579 individuals from three different primary health care centers and collected information on symptoms through a standardized questionnaire. Our main study finding was an overall population prevalence of 14.34% (95% CI 11.58-17.46%) of post COVID-19. Only 9% of patients were hospitalized in our study. Prevalence was higher in women than men (15.63% versus 13.06%) and the most frequent persistent symptoms were fatigue (44.6%), smell impairment (27.7%) and dyspnea (24.09%). The prevalence of post COVID-19 condition was lower than expected according to other studies published in the literature. The prevalence was higher in women than men, and the most frequent persistent symptoms were fatigue, smell impairment, and dyspnea.

Sections du résumé

BACKGROUND BACKGROUND
The COVID-19 pandemic is a major challenge for health systems, citizens and policymakers worldwide. It is not known how many people are affected with longer term sequelae after acute COVID-19 and a wide range of prevalence estimates have been reported with a high heterogeneity between studies.
METHODS METHODS
We designed a cross-sectional study to estimate the prevalence of post COVID-19 conditions in a community setting. We selected a random sample of 579 individuals from three different primary health care centers and collected information on symptoms through a standardized questionnaire.
RESULTS RESULTS
Our main study finding was an overall population prevalence of 14.34% (95% CI 11.58-17.46%) of post COVID-19. Only 9% of patients were hospitalized in our study. Prevalence was higher in women than men (15.63% versus 13.06%) and the most frequent persistent symptoms were fatigue (44.6%), smell impairment (27.7%) and dyspnea (24.09%).
CONCLUSIONS CONCLUSIONS
The prevalence of post COVID-19 condition was lower than expected according to other studies published in the literature. The prevalence was higher in women than men, and the most frequent persistent symptoms were fatigue, smell impairment, and dyspnea.

Identifiants

pubmed: 35162857
pii: ijerph19031836
doi: 10.3390/ijerph19031836
pmc: PMC8834857
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Environ Res Public Health. 2020 Dec 14;17(24):
pubmed: 33327641
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
Int J Environ Res Public Health. 2021 Apr 20;18(8):
pubmed: 33923972
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
JAMA Netw Open. 2021 Oct 1;4(10):e2128568
pubmed: 34643720
J Infect. 2020 Dec;81(6):e4-e6
pubmed: 32853602
Int J Clin Pract. 2021 Mar;75(3):e13746
pubmed: 32991035
Ann Intern Med. 2021 May;174(5):723-725
pubmed: 33284676
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998
pubmed: 32730238
PLoS One. 2020 Nov 9;15(11):e0240784
pubmed: 33166287
Nat Med. 2021 Apr;27(4):626-631
pubmed: 33692530
Int J Environ Res Public Health. 2021 Mar 05;18(5):
pubmed: 33807869
Thorax. 2021 Apr;76(4):396-398
pubmed: 33172844
Sci Rep. 2021 Aug 9;11(1):16144
pubmed: 34373540
Lancet Respir Med. 2021 Nov;9(11):1275-1287
pubmed: 34627560

Auteurs

Patricia Montenegro (P)

Primary Heath Care Center Sarrià, 08017 Barcelona, Spain.
Teaching Unit in Family Medicine UDACEBA, 08025 Barcelona, Spain.

Irene Moral (I)

Teaching Unit in Family Medicine UDACEBA, 08025 Barcelona, Spain.
Research Unit, Sardenya Primary Health Care Center, 08025 Barcelona, Spain.
Biomedical Research Institute Sant Pau, 08041 Barcelona, Spain.

Alicia Puy (A)

Teaching Unit in Family Medicine UDACEBA, 08025 Barcelona, Spain.
Research Unit, Sardenya Primary Health Care Center, 08025 Barcelona, Spain.
Biomedical Research Institute Sant Pau, 08041 Barcelona, Spain.

Esther Cordero (E)

Teaching Unit in Family Medicine UDACEBA, 08025 Barcelona, Spain.
Primary Health Care Center Roger de Flor, 08013 Barcelona, Spain.

Noa Chantada (N)

Teaching Unit in Family Medicine UDACEBA, 08025 Barcelona, Spain.
Primary Health Care Center Roger de Flor, 08013 Barcelona, Spain.

Lluis Cuixart (L)

Teaching Unit in Family Medicine UDACEBA, 08025 Barcelona, Spain.
Primary Health Care Center Roger de Flor, 08013 Barcelona, Spain.

Carlos Brotons (C)

Teaching Unit in Family Medicine UDACEBA, 08025 Barcelona, Spain.
Research Unit, Sardenya Primary Health Care Center, 08025 Barcelona, Spain.
Biomedical Research Institute Sant Pau, 08041 Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH